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Self-Immolative Polymers as novel pH-responsive gate keepers for 
drug delivery   
M. Gisbert
a,b
 , D. Lozano
a,b
, M. Vallet-Regí
a,b
 * and M. Manzano
a,b
  *
A novel pH-sensitive nanocarrier based on mesoporous silica 
nanoparticles with self-immolative polymers blocking the pore 
openings is presented. Triggered release by acid pH is 
demonstrated, together with their in vitro biocompatibility and 
effective cell internalisation, which makes this new material a 
promising candidate for future applications in cancer treatment.  
Nanotechnology, which has the potential to impact nearly 
every area of modern society, is transforming medicine thanks 
to the development of new smart drug delivery systems.1–3 
Those nanocarriers are expected to bring breakthroughs in 
terms of detecting, diagnosing and treating different forms of 
cancer.4 Recently, Mesoporous Silica Nanoparticles (MSNs) 
have drawn much attention for many biomedical applications, 
especially as drug delivery nanocarriers.5–10 The reason for that 
relays on their unique properties, such as a straightforward 
synthesis, a network of cavities ready available to be filled with 
different payloads, tuneable pore diameters and 
morphologies, facile surface functionalisation and hemo- and 
biocompatibility.11,12 
The textural properties of MSNs, such as large surface areas 
(ca. 1000 m2g-1) and large pore volume (ca. 1 cm3g-1), are 
responsible for their high loading capacities. In fact, 
conventional polymeric nanoparticles suffer from the 
drawback of low drug capacity, usually less than 5% of total 
weight, while MSNs allow much greater values.13,14 
However, MSNs present an open structure of the pores, which 
means that is simple to introduce molecules into their network 
of cavities, but it is also easy for them to diffuse out. This is the 
main reason to place gatekeepers on the entrance of the 
pores, so they can be closed once the cargo is loaded, and 
then opened to allow the drug release. The former process can 
be carried out during the production of the nanocarrier, but 
the later event, opening the gates of the pores, must be done 
on-demand inside the body. This approach leads to stimuli-
responsive nanocarriers,
15
 in which the release of the cargo is 
triggered by a stimulus than can be exogenous (temperature, 
light, magnetic fields or ultrasounds) or endogenous (pH, 
redox potential or specific enzymes or analytes). Those 
systems allow tailoring the release profiles with temporal and 
dosage control. 
Among the available stimuli, pH variations offer the possibility 
of controlling the delivery of drugs to different regions of the 
body such as the gastrointestinal tract, the endosomes or 
lysosomes, or the tumour microenvironment. In particular, the 
slightly acidic lysosomal pH value (4.5-5)
16
 has been used for 
the design of pH-targeted nanocarriers that release their cargo 
once inside the cell.
17,18
 Then, an efficient pH-responsive 
system should respond to this subtle change of pH within this 
organelle, triggering the release of the cargo only inside the 
cells (Scheme 1).  
Scheme 1. Representation of the operating principle of our pH 
sensitive nanocarrier. A change in the pH initiates the dissassembling 
of the self-immolative polymer allowing cargo molecules to diffuse out 
of the MSNs. 
There are many polymeric systems with acid-sensitive bonds 
that can be exploited for designing responsive systems. In this 
sense, there are a new class of polymers, the so-called Self-
Immolative Polymers (SIPs), that disassemble from head to tail 
completely when a specific functional group is cleaved from 
the polymer in response to certain stimuli.19,20 One potential 
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advantage is that it is possible to incorporate prodrugs into the 
polymer chain as pendant groups. These groups would turn 
into actual drugs as the self-immolation takes place.
21
 It is also 
possible to modify the rate at which the chain disassembles to 
achieve a more controlled and sustained drug release.
22
 There 
are many triggers that can initiate the fragmentation of the 
polymer into its building blocks, depending on the molecule 
placed at the end of the polymer. Thus, it is possible to design 
a linear polymer based on a polyurethane backbone with a pH 
sensitive capping molecule as trigger. Dropping the pH would 
cleavage the carbamate linkage of the trigger, which would 
start the sequential 1-6 elimination and decarboxylation 
reactions yielding CO2 and the starting monomer.  
Combining both materials, MSNs and SIPs, in a single 
functional responsive nanocarrier would provide access to the 
benefits of both materials, i.e., the high loading capacity of a 
variety of cargoes into MSNs, and the responsiveness of pH-
sensitive SIPs to control the release. Decoration of the MSNs 
pore entrances with pH-responsive SIP gatekeepers that avoid 
premature release of the cargo and unblock the pores upon pH 
drops, represent a new and promising concept that is explored 
here for the first time (Scheme 2).   
Scheme 2. Schematic representation of the nanocarrier response to 
acid pH. Cleavage of the protecting group generates an intermediate 
that undergoes sequential 1,6-elimination and decarboxylation 
reactions to form the initial monomer, disassembling the immolative 
polymer and allowing the cargo release.    
In this work we have developed a smart nanocarrier able to 
respond to changes in the pH for potential applications in 
cancer treatment. For this purpose, we have selected MSNs as 
carriers and a SIP with a trigger sensitive to acid pH to block 
the pore entrances and prevent premature release. The pH 
sensitivity of the nanosystem was evaluated in-vial showing 
that cargo release took place in acidic conditions, while at 
physiological pH there was almost no release. The 
biocompatibility of the system was evaluated with different 
cells, and internalisation of the nanoparticles was also 
demonstrated. 
MSNs were synthesised via sol-gel method under basic 
conditions using hexadecyltrimethylammonium bromide 
(CTAB) as structure directing agent following a previously 
published method.
23
 The sol-gel method allows a fine control 
on the final composition of the nanoparticles under mild 
conditions.
24,25
 The spherical morphology of the as-produced 
MSNs was confirmed through Scanning Electron Microscopy 
(SEM) and Transmission Electron Microscopy (TEM), as can be 
observed in Figure 1a and 1b, with average sizes of ca. 150 nm 
(see ESI, Figure S3 with Dynamic Light Scattering, DLS, studies). 
Figure 1. (a) SEM images of MSNs; (b) TEM images of MSNs; (c) 
Nitrogen adsorption and desorption isotherms of MSN (black solid 
line), MSN-CS (blue dashed line) and MSN-CS-SIP (red dotted line) 
(inset: pore size distribution determined by the BJH method from the 
desorption branch of the isotherm); (d) XRD patterns of MSN (black 
solid line), MSN-CS (blue dashed line) and MSN-CS-SIP (red dotted 
line).   
Typical adsorption-desorption isotherms of MCM-41-like 
materials with cylindrical pores were observed (Figure 1c), 
with pore diameters centred at ca. 2.7 nm. The characteristic 
hexagonal arrangement of the pores was confirmed through 
low angle X-Ray Diffraction (XRD) analyses (Figure 1d), where 
typical well resolved maxima from well-ordered 2D-hexagonal 
structure with p6mm space group were observed. 
A linear self-immolative polymer was produced to cover the 
pore entrances and avoid premature release of the cargo. We 
employed a polyurethane backbone with a BOC protecting 
group on the terminal amine that acted as a trigger. A pH drop 
would cleave the protecting group and initiate the disassembly 
of the polymer. The SIP was synthesised by a modification of a 
previously published method (Figure 2a),
19
 producing the 
monomer 1 from 4-aminobenzyl alcohol and phenyl 
chloroformate. Then, the polymerisation process using DBTL as 
catalyst and 2 as end-group leaded to the polymeric chain 3 
with an average of about 20 monomers (determined by NMR, 
through the ratio benzylic hydrogens at the molecule tail vs. 
those in the polymeric backbone). 
The self-immolative behaviour of the SIP was confirmed by 
treating the polymer with trifluoroacetic acid in CH2Cl2, which 
are the standard conditions for removing BOC protecting 
groups. After the acid treatment, all characteristic NMR peaks 
of SIP had disappeared (Figure S8), as expected. 
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Figure 2. (a) Schematic representation of the SIP synthesis; (b) Schematic representation of the SIP grafting to the MSNs. 
 
The successful attachment of the SIP to the MSNs was 
achieved through a previous modification of the nanoparticles 
with an alkoxysilane bearing chloride groups at the other end 
(denoted CS) (Figure 2b). Those modified-particles (MSN-CS) 
were characterised through thermogravimetric (TG) analysis 
(Fig. S1), where the increase of weight loss confirmed the 
presence of organic matter, together with elemental analysis 
(Table 1), where the increment of C % verifies the linker 
grafting. The C-H stretching bands from Fourier Transform 
Infrared spectroscopy (FTIR, Fig. S2) also confirmed the 
presence of the linker.  
Addition of polymer 3, previously activated with DIPEA, to the 
MSN-CS leaded to SIP coating (MSN-CS-SIP). XRD analyses 
after functionalisation (Figure 1d) showed that the ordered 
mesostructure survived the process, although the progressive 
reduction of the intensity might be ascribed to the partial 
filling of the pores by some polymer chains, as it was 
previously observed when functionalising MSNs with large 
dendrimers.
26
 The successful SIP coating onto MSNs was 
confirmed through different characterisation techniques. The 
great weight loss observed in TG analyses (Fig. S1) is indicative 
of the great amount of SIP present. FTIR spectrum of MSN-CS-
SIP (Fig. S2) exhibits additional bands to those typical from 
silica materials at ca. 1650 cm-1, typical from C-O stretching 
vibrations from carbamates, verifying the presence of the 
polymer. This is in agreement with the data obtained from N2 
analyses (Table 1), in which the reduction of the surface area 
and pore volume is indicative of the presence of the polymer 
blocking the pore entrances. Finally, the increase of N % in the 
elemental analysis in MSN-CS-SIP confirms the presence of the 
polymer. 
Table1. Main properties of the materials produced in this work. 
Material MSN MSN-CS MSN-CS-SIP 
Organic matter by TG (%) 5.3 14.4 20 
Elemental analysis (%) 
 
C: 3.95 
H: 2.09 
N: 0.06 
C: 9.34 
H: 2.34 
N: 0.11 
C: 10.76 
H: 2.46 
N: 0.53 
Surface area (m
2
/g) 1053 914 671 
Pore Volume (cm
3
/g) 1.05 1.02 0.60 
Pore width (nm) 2.74 2.66 2.19 
Size  (nm); PDI 190; 0.467 190; 0.467 190; 0.358 
Zeta Potential (mV) -35.3 -29.0 -23.8 
Finally, the changes in the zeta potential to less negative 
values confirm the correct functionalisation. However, due to 
the small molecular weight of SIP the size was not affected by 
the functionalisation, either at pH 7.4 or pH 5.  
After confirmation of the polymer grafting on the surface of 
MSN, drug delivery capabilities of the system were evaluated. 
Fluorescent cargo, tris(2,2´-bipyridine)dichloro ruthenium (II) 
denoted as Ru, was loaded into the network of cavities of the 
mesoporous nanoparticles overnight before the blocking the 
pore entrances with the SIP polymer (for further details see 
Supporting Information). The successful Ru loading was 
confirmed by the decrease in the pore volume measured 
through N2 adsorption (data not shown).  
The responsiveness to pH of the system here developed was 
evaluated through an in-vial Ru release from sample MSN-CS-
SIP at 37
o
C using transwells at different pHs, i.e. 7.4 and 5. The 
data from the release kinetics, Figure 3, showed that there was 
almost no cargo release at physiological pH, which means that 
the nanocarrier would travel through the blood stream 
without premature release of the payload. However, when the 
pH of the solution dropped to pH 5, there was a fast release of 
the loaded Ru, as it can be observed in Figure 3. This behaviour 
confirmed that the polymer was disassembling as a 
consequence of the acid pH, opening the pore entrances and 
favouring the release of their cargo only at acid environments.  
Figure 3. In-vial cumulative Ru release (in percentage) vs. time from 
MSN-CS-SIP at physiological and acid pHs (Repeated 3 times each 
measurement; Standard Error of the Mean (SEM)). 
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Moreover, after being exposed to acid pH, the zeta potential 
of MSN-CS-SIP increased from -23.8 mV to -10.7 mV. That 
would confirm that the self-immolation actually took place, as 
its residue is a molecule of 4-aminobenzyl alcohol. 
Once the MSNs covered with the SIPs nanocarrier were fully 
characterised and their pH-sensitive release capabilities 
demonstrated in-vial, the next step was analysing their 
behaviour with cells. The in vitro cytotoxicity study was 
determined by the exposition of MC3T3-E1 pre-osteoblastic 
cells to different amounts of nanoparticles (50, 100, 200 and 
300 µg/mL). Figure 4 shows that none of the studied 
concentrations, except 300 µg/mL, induced significant 
cytotoxicity measured by an Alamar Blue assay (cell viability 
was > 99% that of the control). Similar results were obtained in 
LNCaP tumoral cells (Figure S9).  
Figure  4. (a) MC3T3-E1 cell viability in contact with different concentrations 
of nanoparticles at 24, 48 and 72h of cell culture. Similar proliferation results 
were obtained in LNCaP cells. *p<0.05 vs control without nanoparticles 
(Student´s t-test). (b) Fluorescence microscopy images of LNCaP cells 
incubated with nanoparticles at 2 hours of cell culture. From left to right: 
green fluorescence (nanoparticles with fluorescein) and overlay image with 
blue fluorescence (nuclei). 
Cellular internalization of the nanoparticles was observable by 
fluorescence microscopy and analyzed by flow cytometry in LNCaP 
cells in contact with the nanoparticles (100µg/mL) for 2 hours. No 
fluorescence was observed in the end slices corresponding to the 
external cellular surfaces, suggesting that the nanoparticles did not 
adsorb on the cell membranes. Therefore, we observed that the 
nanoparticles at 100µg/mL were internalized by LNCaP cells. The 
cellular uptake observed by fluorescence microscopy was also 
confirmed by flow cytometry (19.25±1.5% of nanoparticles 
incorporation) in the same cells, at 2 hours. The low cellular 
internalization would be in agreement with the fact that positively 
charged
27
 or targeted
28
 nanocarriers show better cellular 
internalization than those negative, as in the case of MSN-CS-SIP. 
Conclusions 
In conclusion, we have developed for the first time Mesoporous 
Silica Nanoparticles capped with acid responsive Self-Immolative 
Polymers. The cargo release can be triggered by acid pH, typical 
from tumours microenvironments. The biocompatibility of this new 
delivery nanoplatform has been demonstrated with different cell 
types, and the effective nanoparticle internalization has been 
achieved in tumoral cells. We envision that the synergy from MSNs 
carriers and SIPs could be of a great interest for future applications 
in nanomedicine to fight against cancer.  
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